Research ArticleMinireviews
What Can Be Learned from Recent New Drug Applications? A Systematic Review of Drug Interaction Data for Drugs Approved by the US FDA in 2015
Jingjing Yu, Zhu Zhou, Katie H. Owens, Tasha K. Ritchie and Isabelle Ragueneau-Majlessi
Drug Metabolism and Disposition January 2017, 45 (1) 86-108; DOI: https://doi.org/10.1124/dmd.116.073411
Jingjing Yu
Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington
Zhu Zhou
Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington
Katie H. Owens
Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington
Tasha K. Ritchie
Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington
Isabelle Ragueneau-Majlessi
Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleMinireviews
A review of drug disposition and DDIs in 2015 NDAs
Jingjing Yu, Zhu Zhou, Katie H. Owens, Tasha K. Ritchie and Isabelle Ragueneau-Majlessi
Drug Metabolism and Disposition January 1, 2017, 45 (1) 86-108; DOI: https://doi.org/10.1124/dmd.116.073411
Jump to section
- Article
- Abstract
- Introduction
- Metabolism and Enzyme-Mediated DDIs
- Transport and Transporter-Mediated DDIs
- PGx Studies
- PBPK Modeling and Simulations
- Clinically Significant DDIs
- Hepatic Impairment (HI) and Renal Impairment (RI) Studies
- Conclusions
- Acknowledgments
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters
- PDF + SI
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement